Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Added Sugars Drive Insulin Resistance, Hyperinsulinemia, Hypertension, Type 2 Diabetes and Coronary Heart Disease.

Missouri medicine·2023
Same author

Nutraceutical activation of Sirt1: a review.

Open heart·2022
Same author

Nutraceutical Prevention of Diabetic Complications-Focus on Dicarbonyl and Oxidative Stress.

Current issues in molecular biology·2022
Same author

Monounsaturated Fat vs Saturated Fat: Effects on Cardio-Metabolic Health and Obesity.

Missouri medicine·2022
Same author

Ferulic acid and berberine, via Sirt1 and AMPK, may act as cell cleansing promoters of healthy longevity.

Open heart·2022
Same author

Coenzyme Q10 deficiency can be expected to compromise Sirt1 activity.

Open heart·2022

Related Experiment Video

Updated: May 24, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Hydrochlorothiazide: is it a wise choice?

James J DiNicolantonio1

  • 1Wegmans Pharmacy, 500 South Meadow Street, Ithaca, NY 14850, USA. jjdinicol@gmail.com

Expert Opinion on Pharmacotherapy
|March 20, 2012
PubMed
Summary
This summary is machine-generated.

Hydrochlorothiazide (HCTZ) is widely prescribed but lacks evidence for reducing cardiovascular events and may increase risks. Chlorthalidone and indapamide are recommended alternatives due to better data and safety profiles.

More Related Videos

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Related Experiment Videos

Last Updated: May 24, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Clinical Trials

Background:

  • Hydrochlorothiazide (HCTZ) is the most prescribed diuretic in the U.S. despite lacking evidence for reducing mortality or cardiovascular events.
  • Two randomized trials indicated HCTZ may increase cardiovascular death and coronary artery disease (CAD) compared to placebo.
  • Current guidelines do not differentiate between thiazide diuretics, but clinical data favors chlorthalidone and indapamide over HCTZ.

Purpose of the Study:

  • To compare the pharmacological profiles of HCTZ, chlorthalidone, and indapamide.
  • To review surrogate marker data for these diuretics.
  • To analyze clinical trial data comparing HCTZ, chlorthalidone, and indapamide.

Main Methods:

  • Literature review of pharmacological properties.
  • Analysis of surrogate marker studies.
  • Synthesis of data from randomized controlled trials.

Main Results:

  • Chlorthalidone and indapamide possess distinct pharmacological profiles compared to HCTZ.
  • Evidence from surrogate markers and clinical trials suggests superior efficacy and safety for chlorthalidone and indapamide.
  • HCTZ has not demonstrated benefits in reducing cardiovascular outcomes and may carry risks.

Conclusions:

  • The term 'thiazide diuretic' should be revised to 'non-thiazide sulfonamide diuretic' for chlorthalidone and indapamide.
  • Chlorthalidone and indapamide should be recommended over HCTZ due to a stronger evidence base and potential harm associated with HCTZ.
  • Revising diuretic recommendations can improve cardiovascular outcomes and patient safety.